ArticleCancer cell international2025

Correction: Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities.

Leiming Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.